NatAspin H – Circulatory Health & Thrombosis Prevention Supplement (30 Capsules)
- Stock: In Stock
- Brand: Valentis
- Model: Nataspin H
- Weight: 0.05kg
- Dimensions: 12.00cm x 2.00cm x 5.00cm
£19.89
Ex Tax: £19.89
NatAspin H is a specialized dietary supplement designed to improve circulation and reduce the risk of thrombosis. It combines the powerful benefits of nattokinase, a fibrinolytic enzyme derived from the traditional Japanese dish Natto, and hydroxytyrosol, a potent antioxidant. Together, they work to support cardiovascular health, promote normal blood flow, and reduce bad cholesterol (LDL-C).
Key Benefits:
- Improves Circulation: Nattokinase enhances blood flow by reducing platelet aggregation and supporting the breakdown of fibrin, helping to prevent clot formation.
- Cardiovascular Support: Hydroxytyrosol, a natural antioxidant from olives, reduces thromboxane B2 levels, lowering the risk of thrombosis and supporting overall cardiovascular function.
- Cholesterol Reduction: The combination of nattokinase and hydroxytyrosol helps lower LDL-C and triglycerides, promoting healthy cholesterol levels.
- Mitochondrial Function: Supports energy production at the cellular level by enhancing ATP (adenosine triphosphate) levels, improving overall vitality.
- Comprehensive Circulatory Health: Suitable for individuals with increased risk of thrombosis, ischemic heart disease, transient ischemic attack, atrial fibrillation, thrombophlebitis, varicose veins, and related conditions.
Composition (Per Capsule):
- Nattokinase: 100 mg (2000 FU)
- Hydroxytyrosol: 6 mg
- Excipients: Microcrystalline cellulose, capsule shell (hydroxypropyl methylcellulose, titanium dioxide), silicon dioxide, vegetable magnesium stearate.
How to Use:
- Take 1 capsule daily with a glass of water. For optimal results, it is recommended to take the supplement consistently, as advised by a healthcare professional.
Recommended For:
- Prevention of ischemic stroke (AMI)
- Prevention of ischemic heart disease (CHD)
- Transient ischemic attack (TIA)
- Atrial fibrillation
- Thrombophlebitis and post-thrombophlebitis syndrome
- Varicose veins
- Diabetic polyneuropathy
- Vasculitis, scleroderma, and related circulatory conditions
- Management of high cholesterol and hypertension